Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
FDA Guidance Details How Manufacturers Can Make E-Cigs Safer From Battery Explosions And Toxic Nicotine Doses November 27, 2019 Irvin Jackson Add Your Comments In response to growing concerns about the safety of e-cigarettes, federal regulators have issued new guidance explaining how manufacturers can make improvements to vaping products to reduce the risk of battery explosions and nicotine overdoses. The FDA issued a new guidance for industry on November 25, called “Compliance Policy for Limited Modifications to Certain Marketed Tobacco Products”, which sets out premarket review requirements for limited modifications to battery-operated tobacco products and liquid nicotine products. The agency notes it does not intend to enforce violations of premarket review requirements against products modified according to the guidance. However, the agency is encouraging manufacturers to remove the currently marketed products from the market before introducing the new, modified products. LEARN MORE ABOUT VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “We recognize there are certain modifications manufacturers can make to their tobacco products to address a voluntary industry battery standard and to comply with requirements related to safe packaging of liquid nicotine products, known as flow restrictors,” Mitch Zeller, the head of the FDA’s Center for Tobacco Products said in a press release. “We encourage these limited safety-related modifications because they are intended to ensure the public is protected from risks such as battery explosions or accidental exposure to toxic levels of nicotine.” At issue are a series of e-cigarette explosions which have occurred in recent years, mostly linked to lithium ion batteries, and incidents of child nicotine poisoning. The FDA’s Center for Tobacco Products released a report in March 2016 in the journal Tobacco Control, which identified at least 92 reports of electronic cigarette explosions between 2009 and September 2015. Other reports around the same time placed the number of incidents much higher. A report in April 2016 by Ecigone.com indicated there had been nearly 160 exploding or combusting e-cig incidents reported through the media at that time, with many likely going unreported due to the user’s right to privacy or embarrassment to report. It is unclear how many e-cigarette explosions have occurred since. On August 8, 2016, all e-cigarettes and electronic nicotine delivery systems (ENDS) became subject to FDA authority. The agency, along with the U.S. Consumer Product Safety Commission, industry, and Underwriters Laboratories developed a voluntary industry standard known as UL 8139 to address battery-related risks. In addition, in 2015 Congress passed a new law requiring liquid nicotine containers to have special packaging making them difficult for children to open. However, making those changes will mean some products classify, technically, as new tobacco products, which would usually require a premarket review. The FDA is indicating it will not enforce that if they are changing the products to meet the UL 8139 battery standard, or the restricted-flow requirements for liquid nicotine containers in the Child Nicotine Poisoning Prevention Act of 2015. Electronic Cigarette Health Problems The guidance, which is not legally binding on manufacturers, comes as e-cigarettes and similar products face extensive scrutiny due to widespread underage use and an outbreak of vaping-related lung injuries. The U.S. Centers for Disease Control and Prevention (CDC), the FDA and state agencies are currently investigating about 2,200 cases of vaping lung injuries, which have resulted in about 50 deaths. Investigators suspect the cause of the illnesses were aftermarket THC products used with vaping devices that contained Vitamin E acetate, but the illnesses are still under investigation. In addition to the risk of e-cigarette respiratory illnesses, there is also now a new generation of teens addicted to JUUL, which contains high levels of nicotine and was aggressively marketed to individuals who were not prior cigarette smokers. A growing number of JUUL injury lawsuits are now being pursued against the manufacturers, alleging that the products were illegally marketed to kids while failing to disclose that each of the e-cigarette pods contain more nicotine than a pack of tobacco cigarettes. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Children, E-Cigarettes, Electronic Cigarettes, Explosions, Juul, Liquid Nicotine, Lithium Ion Batteries, Nicotine, Poison, Respiratory, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: today) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: today) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)